China is rapidly overtaking the US in global oncology clinical trials, accounting for more than half of late-stage study activity by 2025.

Eli Lilly is set for another win in the glucagon-like peptide-1 (GLP-1) sector as its triple-g agonist, retatrutide, has succeeded in type 2 diabetes and obesity. Marking the four ...

J&J's MonumenTAL-6 results add to the growing body of evidence touting Talvey and Tecvayli’s use in earlier multiple myeloma treatment lines.

Devonian Health Group has received authorisation from Health Canada for its CTA to begin a Phase II/III study of Thykamine cream to treat mild-to-moderate atopic dermatitis in paediatric patients.

The funds will help Crystalys progress its clinical-stage development efforts and commercialisation plans for its gout drug, dotinurad.

The Phase III trial failed to meet its co-primary endpoints or any of its key secondary endpoints. Credit: Ton Photographer 4289 / Shuttertock.com Kolon TissueGene’s stock has dropped after a Phase ...

The pre-screening process uses AI to analyse patient profiles and identify possible matches for trials before full review. Credit: metamorworks / Shutterstock.com. Massive Bio has partnered with FOMAT ...

The ongoing Phase II trial is being conducted as part of a DAIR approach and is fully enrolled. Credit: PaeGAG / Shutterstock.com. Trellis Bioscience has closed a $9m Series C funding round to support ...

Bayer and Henry Ford Health intend to work together throughout clinical trials. Credit: Stock-Asso / Shutterstock.com. Bayer and Henry Ford Health have entered a strategic research partnership aimed ...

Nuvation Bio’s glioma drug has touted a 36-month progression-free survival (PFS) rate of 79% with nearly 40 months of follow-up, with its advancement to a pivotal study now set. The Phase II (J201; ...

GSK will no longer progress the development of camlipixant in RCC, but it will continue efforts on the drug in irritable bowel syndrome. Credit: New Africa / Shutterstock.com. GSK’s $2bn bid on Bellus ...